Secondary Logo

Journal Logo

Original Article

Evaluation of Outpatient Antibiotic Use in Beijing General Hospitals in 2015

Yang, Chuan; Cai, Wen-Qiang; Zhou, Zi-Jun

Author Information
doi: 10.4103/0366-6999.198929
  • Free

Abstract

INTRODUCTION

The use of antibiotics is known to be the single most important driver of antibiotic resistance. Nevertheless, antibiotic misuse remains common,[1] particularly in China, which has the world's most rapid growth of antibiotic resistance.[23] The rate of antibiotic prescriptions for both inpatients and outpatients is high in China.[4] In the primary care system, which comprises a network of mostly rural facilities that are responsible for approximately two-thirds of health-care provision in China, more than 60% of antibiotic prescriptions were found to be inappropriate. The key concerns were the overprescribing of antibiotics. Between 78% and 93% of respiratory infections were treated with antibiotics, a rate that is far in excess of the levels recommended by the World Health Organization.[56] Antibiotic resistance results in a lack of effective drugs to fight infections, as well as increased health-care cost, prolonged hospital stay, and substantially increased social and economic burdens.[5]

In 2009, the Chinese government launched a national program of health-care reform and implemented the National System for Basic Drugs. One of the goals was to urge the public to seek care scientifically, and safe, effective, and appropriate use of medicines was proposed.[7] The progression of China's health-care reform and the implementation of the pharmaceutical policy represent a positive change in ensuring the appropriate use of antibiotics in China.[8] However, the measures adopted to date are far from adequate[4] and inappropriate use of antibiotics in China remains common.[69] In this study, we analyzed the prescriptions of antibiotics and evaluated the rationality of antibiotic use among outpatients in Beijing's general hospitals during 2015.

METHODS

Data collection

In this study, we collected basic medical insurance claim data from January 1, 2015, to December 31, 2015, in Beijing's 507 general hospitals including 44 tertiary general hospitals, 60 secondary general hospitals, and 403 primary general hospitals. The data covered the patients’ demographic information, medicines prescribed (including medicine name, dose, and duration), and expenditure. Stratified random sampling was conducted and 30% of hospitals were selected as the study sample (13 tertiary hospitals, 18 secondary hospitals, and 120 primary hospitals).

Statistical analysis

SQL Server 2008 (Microsoft Corporation Inc., Redmond, WA, USA) was used for the storage, retrieval, and manipulation of all data. SPSS 20.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. P < 0.05 was considered statistically significant.

We performed a descriptive analysis of outpatient antibiotic prescribing. The descriptive indexes included antibiotic expenditure, number of antibiotic prescriptions, average cost per antibiotic prescription, antibiotic prescriptions as a percentage of all prescriptions (defined as the number of antibiotic prescriptions divided by the total number of prescriptions), injectable antibiotic prescriptions as a percentage of all antibiotic prescriptions (defined as the number of injectable antibiotic prescriptions divided by the total number of antibiotic prescriptions), and antibiotic combinations as a percentage of all antibiotic prescriptions (defined as the number of antibiotic combination prescriptions divided by the total number of antibiotic prescriptions). Differences in rates among different general hospital ratings were compared using the Chi-squared test.

The Anatomical Therapeutic Chemical Classification/defined daily doses (ATC/DDDs) system developed by the World Health Organization serves as a tool for drug utilization research to improve quality of drug use.[10] The ATC/DDD system is independent of package size and sales price. It allows comparisons not only within an institution but also within a region, a country, or even internationally.[1011] Rationality of antibiotic use was analyzed quantitatively by calculating the frequency of drug use (DDDs) and drug utilization index (DUI). DDDs were defined as the total amount of drugs prescribed during the study divided by the DDD value. The DDD value increases with the frequency of drug use. DDD values were obtained from the ATC/DDD index (2010) of the WHO Collaborating Center for Drugs Statistics Methodology and the Chinese Pharmacopoeia, 2015.[1012] DUI values were defined as DDDs divided by the medication duration. DUI values for an antibiotic exceeding 1.0 indicate the existence of inappropriate use.[1011]

RESULTS

Outpatient antibiotic prescriptions in general hospitals in Beijing, 2015

Table 1 provides a description of outpatient antibiotic prescribing in general hospitals in Beijing. In primary general hospitals, 721,930 antibiotics were dispensed, representing 5.09% of all prescriptions and costing RMB 46.98 million Yuan. In secondary general hospitals, 613,520 antibiotics were dispensed, representing 5.06% of all prescriptions and costing RMB 82.58 million Yuan. In tertiary general hospitals, 822,480 antibiotics were dispensed, representing 2.53% of all prescriptions and costing RMB 116.38 million Yuan. The percentage of antibiotic prescriptions among all prescriptions in tertiary hospitals was significantly lower than that in the primary and secondary general hospitals (χ2 = 267,971.360, P < 0.01). The correlation between the proportion of antibiotic prescriptions among all prescriptions and patient age is shown in Figure 1. In primary and secondary hospitals, the proportion of antibiotic prescriptions decreased with increasing patient age. The decrease in the proportion of antibiotic prescriptions was similar for both primary and secondary hospitals. In tertiary hospitals, the proportion of antibiotic prescriptions decreased with patient age up to 70 years, with a subsequent increase with patient age. Furthermore, the initial decrease in the proportion of antibiotic prescriptions for tertiary hospitals was smaller than those observed for primary and secondary hospitals.

T1-7
Table 1:
Outpatient antibiotic prescriptions in Beijing general hospitals, 2015
F1-7
Figure 1:
Proportion of antibiotic prescriptions among all prescriptions in Beijing general hospitals by age group.

Injectable antibiotic prescriptions represented 6.55%, 19.02%, and 21.41% of all antibiotic prescriptions in primary, secondary, and tertiary general hospitals, respectively, with significantly lower rates in primary hospitals compared with those in secondary and tertiary hospitals (χ2 = 70,785.984, P < 0.01). The correlation between the proportion of injectable antibiotic prescriptions among all antibiotic prescriptions and patient age is shown in Figure 2. The proportion of injectable antibiotic prescriptions among the total antibiotic prescriptions for all general hospitals decreased initially with increasing patient age, with a subsequent increase observed after the age of 50 years in primary hospitals, 60 years in secondary hospitals, and 40 years in tertiary hospital.

F2-7
Figure 2:
Proportion of injectable antibiotic prescriptions among all antibiotic prescriptions in Beijing general hospitals by age group.

The average cost per antibiotic prescription in primary, secondary, and tertiary general hospitals was RMB 65.08, 134.60, and 141.50 Yuan, respectively. The correlation between average cost per antibiotic prescription and patient age is shown in Figure 3. In primary hospitals, the average cost per antibiotic prescription remained almost constant with increasing patient age, while in secondary and tertiary hospitals, it increased with patient age. The increasing average cost per antibiotic prescription of tertiary hospitals was higher than that of secondary hospitals.

F3-7
Figure 3:
Average cost per antibiotic prescription among outpatients in Beijing general hospitals by age group.

Table 2 provides a description of antibiotic combinations prescribed to outpatients in general hospitals in Beijing during 2015. Dual antibiotics combination prescriptions in primary, secondary, and tertiary general hospitals represented 2.89%, 6.77%, and 8.42% of all antibiotic prescriptions while prescriptions for combinations of three or more antibiotics represented 0.06%, 0.97%, and 1.75% of all antibiotic prescriptions, respectively. Overall, antibiotic combinations prescribed to outpatients were relatively low as a percentage of all antibiotics prescriptions in general hospitals in Beijing, with significantly increasing percentages as the rating of hospitals increased from primary to tertiary (χ2 = 31,911.939, P < 0.01). Dual antibiotic combinations were the most frequently prescribed, accounting for more than 80% of all antibiotic combination prescriptions. The correlation between antibiotic combination prescriptions as a proportion of all antibiotic prescriptions and patient age is shown in Figure 4. In primary hospitals, the percentage of antibiotic combination prescriptions remained almost constant with increasing patient age while the percentage increased with patient age in secondary and tertiary hospitals.

T2-7
Table 2:
Outpatient antibiotic combinations in Beijing general hospitals, 2015
F4-7
Figure 4:
Antibiotic combination prescriptions as a proportion of all antibiotic prescriptions among outpatients in Beijing general hospitals by age group.

Outpatient antibiotic expenditures

Table 3 provides the expenditure for each antibiotic as a proportion of the total antibiotic expenditure in general hospitals in Beijing during 2015. Expenditure for the top twenty antibiotics in primary, secondary, and tertiary general hospitals was RMB 42.92, 65.89, and 83.26 million Yuan representing 91.35%, 79.79%, and 71.54% of the expenditures for the total antibiotic expenditure, respectively. Compared with secondary and tertiary hospitals, antibiotic use in primary hospitals was predominantly confined to the top twenty antibiotics. The top two antibiotics in terms of expenditures were cephalosporins in all three general hospitals’ ratings.

T3-7
Table 3:
Expenditure for each antibiotic as a proportion of the total antibiotic expenditure among outpatients in Beijing general hospitals, 2015 (ranking by proportion)

Rationality of antibiotic use

Table 4 provides the DDDs and DUI values for outpatient antibiotic prescriptions for general hospitals in Beijing during 2015. To evaluate the rationality of antibiotic use, we calculated the DDDs and DUI values of the top 15 antibiotics in terms of expenditure (with the exception of polymyxin B, for which a DDD value was not assigned). In terms of DDDs rankings, cephalosporins accounted for the top five antibiotics (with the exception of the third most commonly used antibiotic, azithromycin enteric-coated capsules) in primary hospitals, the top six antibiotics in secondary hospitals, and the top eight antibiotics (with the exception of the fifth, fosfomycin trometamol powder) in tertiary hospitals. Thus, cephalosporins represent the most frequently prescribed class of antibiotic in clinical practice and the first choice of antimicrobial agent among clinicians. In primary hospitals, antibiotics with DUI >1 were azithromycin enteric-coated capsules, compound cefaclor tablets and nifuratel nysfungin vaginal soft capsules. In secondary hospitals, antibiotics with DUI >1 were amoxicillin and clavulanate potassium dispersible tablets (7:1) and cefonicid sodium for injection. In tertiary hospitals, antibiotics with DUI >1 were cefminox sodium for injection and amoxicillin sodium and sulbactam sodium for injection.

T4-7
Table 4:
DDDs, DUI values for outpatient antibiotics prescriptions in Beijing general hospitals, 2015 (ranking by DDDs)

DISCUSSION

In this study, we analyzed the data for antibiotic prescriptions among outpatients of general hospitals in Beijing during 2015 to evaluate the current situation in terms of antibiotic prescribing patterns and rationality of use in this population.

The results of our analysis showed that antibiotic prescriptions as a proportion of all prescriptions during the study were far below the proportion of antimicrobial agent prescriptions that is recommended 20% by the guidelines for the clinical application of antibiotics in China.[13] The proportion in tertiary hospitals was lower than that reported nationwide in 2012 (estimated to be 10%).[14] It was also lower than that reported in another study in Hubei Province.[15] However, compared with the proportion in the United States[16] and some European countries,[17] such as Sweden, where antibiotic prescriptions represent 1.1% of all prescriptions,[14] the proportion remains high in Beijing tertiary hospitals. In primary general hospitals, the proportion in Beijing was also lower than that in other provinces, such as Jilin and Jiangsu Province.[5] Compared with other countries, the proportion in Beijing primary general hospitals is relatively higher than that in the United States and other developed countries,[18] although it is comparable to that in India and South Korea.[1920] Antibiotic prescriptions represented significantly higher proportions of all prescriptions in primary and secondary hospitals than that in tertiary hospitals. This shows that antibiotics are more frequently prescribed in the primary care setting, thus increasing the risk of inappropriate antibiotic use. The primary and secondary general hospitals include most of the township health centers and county hospitals. The application of antibiotics in these medical institutions has a great impact on antibiotic resistance in rural areas.[21] Antibiotic prescriptions as a proportion of all prescriptions showed a decreasing trend with increasing patient age. The morbidity of most diseases increases with patient age, with a concomitant increase in drug use for the disease; therefore, antibiotic prescriptions as a proportion of all prescriptions may show a relative decrease.

The WHO recommends that oral antibiotics should be given priority in antibiotic use and injectable antibiotics should be used only when necessary.[22] The analysis showed that injectable antibiotic prescriptions as a proportion of all antibiotic prescriptions were lower than recommended by the WHO.[23] Injectable antibiotic prescriptions as proportions of all antibiotic prescriptions in secondary and tertiary hospitals were significantly higher than that in primary hospitals. In a nationwide study, the proportion is estimated to be 20% in tertiary hospitals, which is similar to that in Beijing, while in Sweden, the proportion is estimated to be only 0.1%.[14] Injectable antibiotics are absorbed rapidly, with a significant curative effect that mitigates the disease effectively and efficiently. The patients in secondary and tertiary hospitals are usually in a more serious condition than those in primary hospitals. Thus, injectable antibiotics may be more frequently applied in secondary and tertiary hospitals. However, in this setting, the consequences of serious adverse drug reactions are difficult to control.[24] Therefore, injectable antibiotics should be used only when necessary and the application should be supervised rigorously.

Average cost per antibiotic prescription in primary general hospitals was RMB 65.08 Yuan, which was similar to the cost of RMB 60 Yuan reported in a nationwide survey in 2009.[25] The average cost per antibiotic prescription in secondary and tertiary hospitals was significantly higher than that in primary hospitals. Two hypotheses may explain this observation. First, patients develop more severe and complicated disease in secondary and tertiary general hospitals than in primary hospitals, which may lead patients to be treated with more effective drugs or antibiotic combinations at high cost. Second, this could be accounted for the cumulative effects of increased drug prices in secondary and tertiary hospitals that have not completely cancelled the rates of drug price addition,[26] and also the financial incentives offered to motivate clinicians to prescribe more expensive drugs in some hospitals.[6]

Prescriptions for antibiotic combinations represent a low proportion of all antibiotic prescriptions although the proportion increased with the rating of the hospital from primary to tertiary. A study showed that almost 30% of all antibiotic prescriptions were for antibiotic combinations in tertiary hospitals in Hubei Province.[15] The proportion in Beijing was significantly lower than that in Hubei Province. Antibiotic combinations were prescribed for serious diseases or patients who were infected by multiple microorganisms to provide broad-spectrum antibacterial efficacy.[27] Inappropriate use of antibiotic combinations may cause adverse events such as increasing the selective pressure of antimicrobial agents and driving the acquisition of antibiotic resistance.[28] Thus, the relevant guidelines should be followed rigorously when prescribing antibiotic combinations.

In terms of both DDDs and expenditure rankings, the top-ranking antibiotics were mainly cephalosporins. Second and third generation cephalosporins such as cefixime and cefuroxime axetil were in the majority. This reflects the position of cephalosporins as the first choice of antimicrobial agents, with cephalosporins being the most frequently prescribed class of antibiotic in clinical practice. Cephalosporins have a broad antibacterial spectrum, high antibacterial activity, low toxicity, and are also β-lactamase resistant. Thus, cephalosporins are used extensively in clinical practice.[29] Because of stability and low price, amoxicillin and clavulanate potassium and azithromycin were also among the top-ranking antibiotics in terms of DDD values in primary and tertiary hospitals.[30] There were 3, 2, and 2 antibiotics with DUI >1 in primary hospitals, secondary hospitals, and tertiary hospitals, respectively. DUI >1 demonstrates that the medicine is overused in terms of frequency and dose,[1011] thus indicating inappropriate use of these antibiotics. This information should be regarded as highly important and the use of these antibiotics should be carefully controlled and managed.

This study had several limitations. First, the study was conducted in a single city, meaning that the results may not be generalizable either provincially or nationally in China. Second, the ATC/DDD system was only used to evaluate antibiotic use among adults and antibiotic use among children and adolescents requires more research.

In conclusion, antibiotic use in Beijing general hospitals is generally low; however, inappropriate antibiotic use still exists. Antibiotics used inappropriately should be subject to rigorous control and management. Public policy initiatives to promote the judicious use of antibiotics are required, such as increased financial support, separation of drug sales from the operation facility, and training of medical professionals.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

REFERENCES

1. Bell M. Antibiotic misuse: A global crisis JAMA Intern Med. 2014;174:1920–1 doi: 10.1001/jamainternmed.2014.3289
2. Yezli S, Li H. Antibiotic resistance amongst healthcare-associated pathogens in China Int J Antimicrob Agents. 2012;40:389–97 doi: 10.1016/j.ijantimicag.2012.07.009
3. Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li L. Changes in Chinese policies to promote the rational use of antibiotics PLoS Med. 2013;10:331–43 doi: 10.1371/journal.pmed.1001556
4. Quan-Cheng K, Jian-Guo W, Xiang-Hua L, Zhen-Zhen L. Inappropriate use of antibiotics in children in China Lancet. 2016;387:1273–4 doi: 10.1016/S0140-6736(16)30019-8
5. Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and prescription of antibiotics in primary health care settings in China JAMA Intern Med. 2014;174:1914–20 doi: 10.1001/jamainternmed.2014.5214
6. Yip W, Powell-Jackson T, Chen W, Hu M, Fe E, Hu M, et al Capitation combined with pay-for-performance improves antibiotic prescribing practices in rural China Health Aff (Millwood). 2014;33:502–10 doi: 10.1377/hlthaff.2013.0702
7. Chen Z. Launch of the health-care reform plan in China Lancet. 2009;373:1322–4 doi: 10.1016/S0140-6736(09)60753-4
8. Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China – A major future challenge Lancet. 2009;373:30 doi: 10.1016/S0140-6736(08)61956-X
9. Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: An exploratory analysis Health Policy. 2009;90:32–6 doi: 10.1016/j.healthpol.2008.09.002
10. ATC/DDD Methodology. ATC/DDD Index – International Language for Drug Utilization Research, 12 October 2009.Last accessed on 2016 Nov 26 Oslo WHO Collaborating Centre for Drug Statistics Methodology Available from: http://www.whocc.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system
11. Akalin S, Kutlu SS, Cirak B, Eskiçorapci SY, Bagdatli D, Akkaya S. Application of ATC/DDD methodology to evaluate perioperative antimicrobial prophylaxis Int J Clin Pharm. 2012;34:120–6 doi: 10.1007/s11096-011-9601-3
12. Tang G, Shen SChen XQ, Jin YY, Tang G. Antibiotics The New Pharmacology. 201417th ed Beijing People's Medical Publishing House:34–90
13. National Health and Family Planning Commission of the People's Republic of China. Regulation on the Clinical Application of Antibiotics.Last accessed on 2016 Nov 26 Beijing Government of China; 7 May 2013 Available from: http://www.nhfpc.gov.cn/zhuzhan/xwfbh/201305/ e1a64829a869405e9d378191d00d860b.shtml
14. Sun J, Shen X, Li M, He L, Guo S, Skoog G, et al Changes in patterns of antibiotic use in Chinese public hospitals (2005-2012) and a benchmark comparison with Sweden in 2012 J Glob Antimicrob Resist. 2015;3:95–102 doi: 10.1016/j.jgar.2015.03.001
15. Xie DS, Xiang LL, Hu Q, Fu XY, Wang HF, Lai RP, et al Antibiotic use in Chinese hospitals: A multicenter point-prevalence study Public Health. 2015;129:576–8 doi: 10.1016/j.puhe.2015.02.010
16. Lee GC, Reveles KR, Attridge RT, Lawson KA, Mansi IA, Lewis JS 2nd, et al Outpatient antibiotic prescribing in the United States 2000 to 2010 BMC Med. 2014;12:1–8 doi: 10.1186/1741-7015-12-96
17. Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006 Clin Infect Dis. 2009;49:1496–504 doi: 10.1086/644617
18. Polk RE, Hohmann SF, Medvedev S, Ibrahim O. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals Clin Infect Dis. 2011;53:1100–10 doi: 10.1093/cid/cir672
19. Sharma M, Eriksson B, Marrone G, Dhaneria S, Lundborg CS. Antibiotic prescribing in two private sector hospitals;one teaching and one non-teaching: A cross-sectional study in Ujjain, India BMC Infect Dis. 2012;12:155 doi: 10.1186/1471-2334-12-155
20. Sohn HS, Oh OH, Kwon JW, Lee YS. Higher systemic antibiotic consumption in a population of South Korea (2008-2009) Int J Clin Pharmacol Ther. 2013;51:585–92 doi: 10.5414/CP201827
21. Linbo Z, Qiang S, Cheng L, Malin G. Analysis on consumption of antibiotics in township health centers based on ATC/DDD method Chin J Public Health. 2014;30:290–3 doi: 10.11847/zgggws2014-30-03-11
22. WHO Policy Perspectives on Medicines. Promoting Rational Use of Medicines: Core Components.Last accessed on 2016 Nov 26 Geneva World Health Organization; September 2002 Available from: http://www.apps.who.int/medicinedocs/collect/medicinedocs/pdf/h3011e/h3011e.pdf
23. World Health Organization. How to Improve the Use of Medicines by Consumers. 2007Last accessed on 2016 Nov 26 Geneva World Health Organization Available from: http://www.apps.who.int/medicinedocs/index/assoc/s14229e/s14229e.pdf
24. Baqui AH, Saha SK, Ahmed AS, Shahidullah M, Quasem I, Roth DE, et al Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: A randomised, open-label, equivalence trial Lancet Glob Health. 2015;3:e279–87 doi: 10.1016/S2214-109X(14)70347-X
25. Li Y, Xu J, Wang F, Wang B, Liu L, Hou W, et al Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids Health Aff (Millwood). 2012;31:1075–82 doi: 10.1377/hlthaff.2010.0965
26. Ying P, Fen L, Chunlin J. Practice and consideration of medical service price adjustment based on the cancellation of drug markup Chin Health Resour. 2014;6:419–21 doi: 10.3969/j.issn.1007-953X.2014.06.012
27. Kotwani A, Holloway K. Trends in antibiotic use among outpatients in New Delhi, India BMC Infect Dis. 2011;11:99 doi: 10.1186/1471-2334-11-99
28. Huttner B, Goossens H, Verheij T, Harbarth S. CHAMP consortium. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries Lancet Infect Dis. 2010;10:17–31 doi: 10.1016/S1473-3099(09)70305-6
29. Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: A literature review J Emerg Med. 2012;42:612–20 doi: 10.1016/j.jemermed.2011.05.035
30. Qiang S, Linbo Z, Chen L, Malin G. Analysis on the antibiotic prescriptions in rural medical institutions based on anatomical therapeutic chemical drug classification Chin Health Econ. 2013;32:43–5 doi: 10.7664/CHE20131213

Edited by: Li-Min Chen

Keywords:

Antibiotic; General Hospitals; Rationality

© 2017 Chinese Medical Association